Global /United States /Healthcare /Medical Devices /TIVC

Valion Bio, Inc.

TIVC

• NASDAQ: TIVC • Delayed

0.9600USD -5%

As of 13 June 2026, Valion Bio, Inc. has a market cap of $2.76M USD, ranking #46399 globally and #5888 in the United States. It ranks #4113 in the Healthcare sector, and #866 in the Medical Devices industry.

Global Rank

46399

Country Rank

5888

Sector Rank

4113

Industry Rank

866

Key Stats

Market Cap

$2.76MUSD

Enterprise Value

-$3.49MUSD

EBITDA (TTM)

-$7.89MUSD

Net Income (TTM)

-$8.88MUSD

PB Ratio

0.2

Company Profile

Country (HQ)

United States

Sector

Healthcare

Industry

Medical Devices

CEO

Michael Handley open_in_new

Employees

Founded

2016

IPO

11 Nov 2021

Website

tivichealth.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-5%	-18%	2.7%	-24%	-64%	-34%	-85%	-100%	-100%

News

TIVC Analyst Forecasts

Markets

Exchange	Ticker	Price	Quotes
NASDAQ MIC: XNAS PRIMARY	TIVC Tivic Health Systems Inc ISIN: US8887053085 Shares Out.: Shares Outstanding: 2.878M¹ Shares Float: 2.797M² TV: TradingView: NASDAQ: TIVC SA: Stock Analysis: NASDAQ: TIVC YF: Yahoo Finance: TIVC GF: Google Finance: NASDAQ: TIVC NQ: NASDAQ: TIVC BA: Barron's: TIVC MS: Morningstar: XNAS: TIVC	0.9600 USD	TV: TradingView: NASDAQ: TIVC SA: Stock Analysis: NASDAQ: TIVC YF: Yahoo Finance: TIVC GF: Google Finance: NASDAQ: TIVC NQ: NASDAQ: TIVC BA: Barron's: TIVC MS: Morningstar: XNAS: TIVC

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Valion Bio, Inc.

Valion Bio, Inc. operates as a late-stage immunotherapeutics company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company’s pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications. In addition, it offers CDMO services. The company was formerly known as Tivic Health Systems, Inc. and changed its name to Valion Bio, Inc. in April 2026. The company was incorporated in 2016 and is based in San Antonio, Texas.

Similar Companies

Industry: Medical Devices (United States)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 6M%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 6M%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 6M%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 5M%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 4M%	38.3	United States
Boston Scientific Corp. NYSE: BSX	$84.93B 3M%	24.5	United States

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Medtronic plc NYSE: MDT	$101.9B 4M%	22.2	Ireland
EssilorLuxottica Société anonyme EPA: EL	$97.46B 84.32B EUR 4M%	36.7	France
HOYA Corp. TSE: 7741	$61.41B 9.83T JPY 2M%	40.0	Japan
Siemens Healthineers AG XETRA: SHL	$45.47B 39.34B EUR 2M%	18.7	Germany
Alcon Inc. SIX: ALC	$36.38B 28.99B CHF 1M%	37.9	Switzerland
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. SHE: 300760	$30.06B 203.66B CNY 1M%	26.0	China

chevron_leftBack